ELOX CIK: 1035354

Eloxx Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.0
FY22:
−31.8
FY23:
−14.3
FY24:
−4.72
FY25:
−6.33
Change from FY21 to FY25
millions USD
FY21:
2.06
FY22:
−0.07
FY23:
0.31
FY24:
0.04
FY25:
0.00
Change from FY21 to FY25
millions USD
FY21:
50.8
FY22:
8.81
FY23:
−4.08
FY24:
3.44
FY25:
11.0
millions USD
FY21:
17.8
FY22:
−23.1
FY23:
−18.1
FY24:
−1.24
FY25:
4.68
(positive)
Change from FY21 to FY24
millions USD
FY21:
−35.1
FY22:
−31.9
FY23:
–
FY24:
−4.72
FY25:
–

All amounts in millions USD Data sources:SEC EDGARTwelve Data